Evidence map›Paper›PMID 27303574›Full record

ArticleThe Pan African medical journal2016

[Cutaneous Merkel cell carcinoma: role of 18FDG PET-CT].

Guensi Amal, Taleb Sara, Cherkaoui Salhi Ghofrane, Ait Idir Malika, Houjami Majdouline, Sahraoui Souha, Benider Abdelatif, Touil Najoua, Benmoussa Ghita, Baroudi Zineb and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in The Pan African medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Guensi AmalService de Médecine Nucléaire, CHU Ibn Rochd, Rabat, Maroc.
Taleb SaraService de Médecine Nucléaire, CHU Ibn Rochd, Rabat, Maroc.
Cherkaoui Salhi GhofraneService de Médecine Nucléaire, CHU Ibn Rochd, Rabat, Maroc.
Ait Idir MalikaService de Médecine Nucléaire, CHU Ibn Rochd, Rabat, Maroc.
Houjami MajdoulineService d'Oncologie Radiothérapie, CHU Ibn Rochd, Rabat, Maroc.
Sahraoui SouhaService d'Oncologie Radiothérapie, CHU Ibn Rochd, Rabat, Maroc.
Benider AbdelatifService d'Oncologie Radiothérapie, CHU Ibn Rochd, Rabat, Maroc.
Touil NajouaService de Radiologie des Urgences, CHU Ibn Rochd, Rabat, Maroc Taleb Sara, Service de Médecine Nucléaire, CHU Ibn Rochd, Rabat, Maroc.
Benmoussa GhitaService de Radiologie des Urgences, CHU Ibn Rochd, Rabat, Maroc Taleb Sara, Service de Médecine Nucléaire, CHU Ibn Rochd, Rabat, Maroc.
Baroudi ZinebService de Radiologie des Urgences, CHU Ibn Rochd, Rabat, Maroc Taleb Sara, Service de Médecine Nucléaire, CHU Ibn Rochd, Rabat, Maroc.
Chikhaoui NabilService de Radiologie des Urgences, CHU Ibn Rochd, Rabat, Maroc Taleb Sara, Service de Médecine Nucléaire, CHU Ibn Rochd, Rabat, Maroc.
Centre Hospitalier Ibn Sina · MAInstitut National d'Oncologie · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Merkel cell carcinoma (MCC) is a rare neuroendocrine carcinoma of the skin with unpredictable evolution and high metastatic potential. This neoplasm usually occurs in the elderly on their sun-exposed areas. CCM constant greed for 18 fluorodeoxyglucose (FDG) defines the role of positron emission tomography (PET) in this pathology. However, no consensus has yet been reached. This study reports the case of a 25 year old woman treated for metastatic MCC, in order to draw attention to this particular tumor and to illustrate the role of 18 FDG PET in the management of this rare entity.

Indexed as

AdultCarcinoma, Merkel CellFemaleFluorodeoxyglucose F18HumansNeoplasm MetastasisPositron Emission Tomography Computed TomographySkin NeoplasmsFluorodeoxyglucose F1818FDGCutaneous Merkel cell carcinomaevolutionPET-CT

Identifiers

PMID27303574
PMCPMC4894725
OpenAlexW2320124809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.